Ocular Therapeutix (NasdaqGM:OCUL) Q3 2026 Earnings call November 09, 2026 08:00 AM ET Company ParticipantsBill Slattery Jr. - VP of Investor RelationsPravin Dugel - Executive Chairman, President, and CEONadia Waheed - Chief Medical OfficerDavid Robinson - Global Chief Commercial OfficerConference Call ParticipantsBiren Amin - AnalystTazeen Ahmad - AnalystSam Rollenhagen - AnalystLisa Walter - AnalystNick Quartapella - AnalystOperatorGood morning, and welcome to the Ocular Therapeutix third quarter 2026 ear ...

Ocular Therapeutix (NasdaqGM:OCUL) Q3 2026 Earnings call November 09, 2026 08:00 AM ET Speaker0Good morning, and welcome to the Ocular Therapeutix third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, we will conduct a question-and-answer session. If you would like to ask a question, please press star one on your telephone. As a reminder, this conference call is being recorded and will be available for replay on the investor relati ...